BioCentury
ARTICLE | Clinical News

Protara: Started a Phase III trial

January 10, 1994 8:00 AM UTC

Gensia Inc. (GNSA), San Diego Product: Protara, adenosine-regulating agent Indication: Treat patients undergoing non-cardiac surgery who are at high risk of developing adverse cardiovascular complicat...